182 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON Page of 4 | next »
Genei Gene descriptioni x Evidencei x Tissuei Braini Single celli Subcelli Canceri Bloodi Cell linei Struct & Inti Prognostic p-valuei x
AADACL3Arylacetamide deacetylase like 3
AADATAminoadipate aminotransferase
ABCA7ATP binding cassette subfamily A member 7
Kidney Renal Clear Cell Carcinoma (TCGA): 3.87e-6
ACANAggrecan
Kidney Renal Papillary Cell Carcinoma (TCGA): 9.14e-9
ACKR2Atypical chemokine receptor 2
ADAAdenosine deaminase
Liver Hepatocellular Carcinoma (TCGA): 7.14e-7
Lung Adenocarcinoma (TCGA): 2.19e-6
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.92e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 4.83e-5
ADAM12ADAM metallopeptidase domain 12
Kidney Renal Clear Cell Carcinoma (TCGA): 1.52e-5
Kidney Renal Clear Cell Carcinoma (validation): 3.63e-5
Ovary Serous Cystadenocarcinoma (validation): 4.88e-5
Lung Adenocarcinoma (validation): 5.11e-4
Lung Adenocarcinoma (TCGA): 5.69e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.76e-4
Ovary Serous Cystadenocarcinoma (TCGA): 6.83e-4
ADMAdrenomedullin
Lung Adenocarcinoma (TCGA): 1.40e-5
Liver Hepatocellular Carcinoma (TCGA): 1.84e-4
Liver Hepatocellular Carcinoma (validation): 3.60e-4
Lung Adenocarcinoma (validation): 4.08e-4
AIF1LAllograft inflammatory factor 1 like
Kidney Renal Papillary Cell Carcinoma (TCGA): 9.12e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 5.74e-5
Liver Hepatocellular Carcinoma (validation): 7.84e-4
ANKRD24Ankyrin repeat domain 24
Liver Hepatocellular Carcinoma (TCGA): 6.49e-6
Liver Hepatocellular Carcinoma (validation): 1.03e-4
ARID3AAT-rich interaction domain 3A
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 3.40e-6
Pancreatic Adenocarcinoma (validation): 9.29e-4
ARL6IP6ADP ribosylation factor like GTPase 6 interacting protein 6
Kidney Renal Clear Cell Carcinoma (TCGA): 2.37e-4
ARSKArylsulfatase family member K
Kidney Renal Clear Cell Carcinoma (TCGA): 1.97e-4
Liver Hepatocellular Carcinoma (TCGA): 3.52e-4
ASAP3ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
Kidney Renal Clear Cell Carcinoma (TCGA): 1.01e-4
Glioblastoma Multiforme (validation): 6.38e-4
ASCL2Achaete-scute family bHLH transcription factor 2
Pancreatic Adenocarcinoma (TCGA): 4.29e-4
ASPSCR1ASPSCR1 tether for SLC2A4, UBX domain containing
Kidney Renal Clear Cell Carcinoma (TCGA): 1.17e-7
Kidney Chromophobe (TCGA): 4.31e-5
Pancreatic Adenocarcinoma (TCGA): 4.34e-4
Ovary Serous Cystadenocarcinoma (validation): 6.04e-4
ATF1Activating transcription factor 1
Kidney Renal Clear Cell Carcinoma (TCGA): 8.27e-6
Liver Hepatocellular Carcinoma (TCGA): 2.61e-4
ATG10Autophagy related 10
Kidney Chromophobe (TCGA): 1.09e-5
Liver Hepatocellular Carcinoma (validation): 6.57e-4
ATIC5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
Liver Hepatocellular Carcinoma (validation): 2.41e-10
Liver Hepatocellular Carcinoma (TCGA): 1.11e-8
Lung Adenocarcinoma (TCGA): 4.54e-4
AXIN2Axin 2
Rectum Adenocarcinoma (TCGA): 1.89e-4
BEAN1Brain expressed associated with NEDD4 1
BTBD10BTB domain containing 10
Kidney Renal Clear Cell Carcinoma (TCGA): 7.85e-6
Liver Hepatocellular Carcinoma (TCGA): 4.23e-4
BZW2Basic leucine zipper and W2 domains 2
Liver Hepatocellular Carcinoma (TCGA): 8.76e-6
Liver Hepatocellular Carcinoma (validation): 2.60e-5
Lung Adenocarcinoma (TCGA): 2.19e-4
Lung Adenocarcinoma (validation): 2.32e-4
Pancreatic Adenocarcinoma (TCGA): 4.19e-4
Breast Invasive Carcinoma (TCGA): 4.65e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 8.91e-4
C1QTNF6C1q and TNF related 6
Lung Adenocarcinoma (TCGA): 1.54e-9
Kidney Renal Clear Cell Carcinoma (TCGA): 8.71e-8
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 2.00e-4
C7orf33Chromosome 7 open reading frame 33
C8orf58Chromosome 8 open reading frame 58
Breast Invasive Carcinoma (validation): 4.99e-4
CALHM3Calcium homeostasis modulator 3
CAPN6Calpain 6
CCDC43Coiled-coil domain containing 43
Kidney Renal Clear Cell Carcinoma (TCGA): 3.47e-6
Kidney Chromophobe (TCGA): 6.09e-5
Liver Hepatocellular Carcinoma (TCGA): 3.73e-4
Liver Hepatocellular Carcinoma (validation): 5.51e-4
CCNB1Cyclin B1
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.11e-10
Liver Hepatocellular Carcinoma (validation): 3.97e-10
Liver Hepatocellular Carcinoma (TCGA): 3.16e-9
Lung Adenocarcinoma (TCGA): 4.69e-7
Kidney Renal Clear Cell Carcinoma (validation): 2.43e-5
Lung Adenocarcinoma (validation): 4.74e-4
Kidney Chromophobe (TCGA): 5.21e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 7.61e-4
CCNE1Cyclin E1
Kidney Renal Clear Cell Carcinoma (validation): 1.31e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 8.00e-5
Lung Adenocarcinoma (TCGA): 8.95e-5
Liver Hepatocellular Carcinoma (validation): 1.47e-4
Pancreatic Adenocarcinoma (TCGA): 2.59e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.90e-4
Liver Hepatocellular Carcinoma (TCGA): 3.53e-4
CCNQCyclin Q
Liver Hepatocellular Carcinoma (TCGA): 3.68e-6
CD276CD276 molecule
Lung Adenocarcinoma (validation): 7.62e-5
Liver Hepatocellular Carcinoma (validation): 6.45e-4
CDCA4Cell division cycle associated 4
Liver Hepatocellular Carcinoma (validation): 3.09e-5
Lung Adenocarcinoma (TCGA): 5.53e-5
Liver Hepatocellular Carcinoma (TCGA): 2.77e-4
Bladder Urothelial Carcinoma (TCGA): 5.81e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 6.53e-4
CDIPTCDP-diacylglycerol--inositol 3-phosphatidyltransferase
Pancreatic Adenocarcinoma (validation): 2.05e-4
CDK7Cyclin dependent kinase 7
Liver Hepatocellular Carcinoma (TCGA): 3.27e-5
Ovary Serous Cystadenocarcinoma (validation): 4.14e-5
CDKN1CCyclin dependent kinase inhibitor 1C
Kidney Renal Clear Cell Carcinoma (validation): 7.92e-5
CERS5Ceramide synthase 5
Kidney Renal Clear Cell Carcinoma (TCGA): 1.19e-4
Lung Squamous Cell Carcinoma (TCGA): 3.16e-4
CKS1BCDC28 protein kinase regulatory subunit 1B
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.67e-7
Liver Hepatocellular Carcinoma (TCGA): 3.42e-6
Lung Adenocarcinoma (TCGA): 4.74e-5
Liver Hepatocellular Carcinoma (validation): 2.33e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 2.37e-4
Pancreatic Adenocarcinoma (TCGA): 8.22e-4
CLDN19Claudin 19
CLDN6Claudin 6
CLEC1AC-type lectin domain family 1 member A
Kidney Renal Clear Cell Carcinoma (TCGA): 1.61e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.20e-4
CLN5CLN5 intracellular trafficking protein
Kidney Renal Clear Cell Carcinoma (TCGA): 8.27e-9
CMTM3CKLF like MARVEL transmembrane domain containing 3
Colon Adenocarcinoma (validation): 3.03e-4
Lung Adenocarcinoma (validation): 4.33e-4
Glioblastoma Multiforme (validation): 5.77e-4
Stomach Adenocarcinoma (TCGA): 7.03e-4
CNPY2Canopy FGF signaling regulator 2
Liver Hepatocellular Carcinoma (validation): 2.83e-5
Liver Hepatocellular Carcinoma (TCGA): 8.96e-5
Glioblastoma Multiforme (validation): 5.90e-4
CSH1Chorionic somatomammotropin hormone 1
CTSVCathepsin V
Lung Adenocarcinoma (TCGA): 1.59e-4
Pancreatic Adenocarcinoma (TCGA): 4.53e-4
Liver Hepatocellular Carcinoma (TCGA): 7.36e-4
CTXND2Cortexin domain containing 2
CYB5R1Cytochrome b5 reductase 1
Kidney Renal Clear Cell Carcinoma (TCGA): 7.22e-8
Rectum Adenocarcinoma (TCGA): 5.09e-4
Page of 4 | next »